Activation of human t cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are hla class ii molecules
- 1 October 1989
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 19 (10) , 1803-1809
- https://doi.org/10.1002/eji.1830191007
Abstract
Toxic shock syndrome toxin-1 (TSST-1)-binding assay using 125I-labeled TSST-1 showed the presence of specific TSST-1 binding in a B cell fraction of human peripheral blood mononuclear cells and L cells transfected with DR2 genes or DR4 genes but not in a T cell fraction and control L cells. Fixation with paraformaldehyde, an inhibitor of antigen processing, did not remove TSST-1-binding activity of the transfectants. Binding of 125I-labeled TSST-1 to the transfectants was reduced by an anti-DR monoclonal antibody. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed the presence of a single band with TSST-1-binding activity and the same migration pattern as DR heterodimers. TSST-1-induced T cell responses, proliferation and interleukin 2 (IL2) production were observed in the presence of the transfectants but not in the presence of control L cells, while concanavalin A-induced IL2 production was observed in the presence of either the transfectants or control L cells. Presence of an anti-DR monoclonal antibody inhibited the TSST-1-induced responses. Paraformaldehyde-fixed Daudi cells were effective in supporting TSST-1-induced IL2 production by T cells. These results indicate that HLA class II molecules directly bind intact TSST-1 and perform an essential role as the TSST-1-binding structures on accessory cells in T cell activation by the toxin.This publication has 35 references indexed in Scilit:
- Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.The Journal of Experimental Medicine, 1988
- Microheterogeneity of HLA-DR4 haplotypes: DNA sequence analysis of LD“KT2” and LD“TAS” haplotypesHuman Immunology, 1987
- Study of the Biological Activities of Toxic Shock Syndrome Toxin‐1Microbiology and Immunology, 1986
- A monoclonal antibody that blocks class II histocompatibility-related immune interactionsHuman Immunology, 1984
- Toxic Shock Syndrome: Clinical, Laboratory, and Pathologic Findings in Nine Fatal CasesAnnals of Internal Medicine, 1982
- Pathologic Findings in Twelve Fatal Cases of Toxic Shock SyndromeAnnals of Internal Medicine, 1982
- A NEW STAPHYLOCOCCAL ENTEROTOXIN, ENTEROTOXIN F, ASSOCIATED WITH TOXIC-SHOCK-SYNDROME STAPHYLOCOCCUS AUREUS ISOLATESThe Lancet, 1981
- Identification and Characterization of an Exotoxin from Staphylococcus aureus Associated with Toxic-Shock SyndromeThe Journal of Infectious Diseases, 1981
- TOXIC-SHOCK SYNDROME ASSOCIATED WITH PHAGE-GROUP-I STAPHYLOCOCCIThe Lancet, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970